Susan Wyrick

Susan Wyrick has extensive experience in finance and accounting, with a focus on technical accounting and complex equity arrangements. Susan has held various leadership roles in notable biotechnology companies such as Sana Biotechnology, Juno Therapeutics, OncoGenex Pharmaceuticals, Emergent BioSolutions, Trubion Pharmaceuticals, Dendreon, and Corixa Corporation. Throughout their career, Susan has worked on revenue recognition, lease accounting, impairment analysis, joint venture accounting, business combinations, and asset acquisitions. Susan has also developed complex valuation models and participated in discussions with the SEC during IPO processes. Susan's work experience spans from 2000 to the present, with their most recent position being Vice President and Controller at Sana Biotechnology, Inc.

Susan Wyrick's education history includes studying Business Administration with a focus on Accounting at the University of Washington - Michael G. Foster School of Business. There is no specific information about the start and end years of their enrollment.